granted
on 13 Nov 2024
Last Applicant/ Owned by
46701 Commerce Center Drive
Plymouth
MI
48170
Serial Number
97096948 filed on 28th Oct 2021
Registration Number
N/A
Correspondent Address
ROGER H. BORA
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for Read More
Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; scientific and technological services in the field of pharmaceuticals featuring pharmacogenomic testing analysis and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how an individual's genetic and non-genetic factors affect their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; scientific and technological services in the field of pharmaceuticals, namely, scientific testing, research, and analysis for the purpose of determining a patient's disease and drug response phenotype through evaluation of chromatin state, genomic regulatory elements, epigenomics, proteomics, metabolomics, transcriptomics, environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of buccal, saliva, blood and other biological samples for the purposes of supporting drug clinical trials and research into the field of new drug development and drug repurposing
N/A
N/A
No 97096948
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Nov 2024 | SOU EXTENSION 2 FILED |
13th Nov 2024 | SOU EXTENSION 2 GRANTED |
13th Nov 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
13th Nov 2024 | SOU TEAS EXTENSION RECEIVED |
11th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th May 2024 | SOU EXTENSION 1 GRANTED |
10th May 2024 | SOU TEAS EXTENSION RECEIVED |
10th May 2024 | SOU EXTENSION 1 FILED |
14th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
11th Oct 2023 | EXPARTE APPEAL TERMINATED |